Bronwen E. Lambson

Also affiliated with South African Medical Research Council, University of the Witwatersrand

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance”.

Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance

Journal of Virology(2025)10.1128/jvi.01730-24

N/A

0.331DataRank · unranked

7 citations

Bronwen E. Lambson, Nonhlanhla N. Mkhize, Chivonne Moodley, Anna Yssel, Thandeka Moyo-Gwete +16 more

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

PLoS Pathogens(2022)10.1371/journal.ppat.1010450

N/A

0.104DataRank · unranked

1 citations

Prudence Kgagudi, Nonkululeko Mzindle, Elin S. Gray, Thandeka Moyo-Gwete, Bronwen E. Lambson +7 more

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.18.427166

N/A

0DataRank · unranked

310 citations

Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen +14 more

SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.06.434193

N/A

0DataRank · unranked

39 citations

Mashudu Madzivhandila, Zanele Makhado, Frances Ayres, Donald Mhlanga, Brent Oosthuysen +22 more

Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage

Nature Communications(2022)10.1038/s41467-022-29579-9

N/A

0DataRank · unranked

38 citations

Josie Everatt, Daniel G. Amoako, Houriiyah Tegally, Constantinos Kurt Wibmer, Anele Mnguni +40 more

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Scientific Reports(2022)10.1038/s41598-022-20141-7

N/A

0DataRank · unranked

14 citations

Cathrine Scheepers, Zanele Makhado, Prudence Kgagudi, Nonkululeko Mzindle, Rutendo Ziki +8 more

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.17.504233

N/A

0DataRank · unranked

2 citations

Cathrine Scheepers, Zanele Makhado, Prudence Kgagudi, Nonkululeko Mzindle, Rutendo Ziki +8 more

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.18.484856

N/A

0DataRank · unranked

1 citations

Prudence Kgagudi, Nonkululeko Mzindle, Elin S. Gray, Thandeka Moyo-Gwete, Bronwen E. Lambson +7 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more

Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody

medRxiv(2025)10.1101/2025.09.04.25334949

N/A

0DataRank · unranked

1 citations

Nonhlanhla N. Mkhize, Leonid Serebryannyy, Tandile Hermanus, Prudence Kgagudi, Haajira Kaldine +15 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape

Cell Reports(2020)10.1016/j.celrep.2020.108430

N/A

0DataRank · unranked

26 citations

Valerie Bekker, Colin Anthony, Simone I. Richardson, Brent Oosthuysen, Thandeka Moyo-Gwete +16 more

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge

Viruses(2025)10.3390/v17020277

N/A

0DataRank · unranked

0 citations

Rosamund Chapman, Alana Keyser, Craig H. Adams, Kealan Benn, Michiel T. van Diepen +6 more

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape

UNC Libraries(2020)10.17615/e8bk-6082

N/A

0DataRank · unranked

0 citations

Quarraisha Abdool Karim, Bronwen E. Lambson, Penny L. Moore, Salim S. Abdool Karim, C Kurt Wibmer +15 more